Penny Stock Trader HUB

[NinaD]

IFCR $0.40 with over $58M In Revenues!

Today's News:

SARASOTA, FL--(Marketwire - 04/05/11) - Integrated Freight Corp. (http://www.integrated-freight.com) (OTC.BB:IFCR - News) (Pinksheets:IFCR - News) today announced the acquisition of Cross Creek Trucking, a Medford, Oregon-based refrigerated freight hauler. In operation since 1986, Cross Creek was founded with just a few trucks and the goal of helping small farmers and receivers along the I-5 corridor. They have since expanded to a fleet of over 115 late model tractors, 170 refrigerated trailers, and 30 dry trailers with 2010 revenues of approximately $28M. Cross Creek currently serves customers across the country with a strong presence in Oregon, Washington, California, Utah, Nevada, Idaho, and Nebraska.

"We're very excited about this acquisition by Integrated Freight," said Michael DeSimone, President and Founder of Cross Creek Trucking. "While we have been a very successful carrier within our own geographical region, joining Integrated's team will allow our customers, our employees, and our company to access numerous additional opportunities nationwide. With the support of Integrated Freight's network of carriers, we will be able to take advantage of greater freight capacity, access a larger customer base, and enjoy the bulk cost savings that Integrated will provide. Locally, we will continue to provide the same safe, reliable service to our clients in the Western United States that we have been for the past 25 years. Nationally, we're ready to expand our base of operations, continue to improve shipping options for our customers, and help to grow Integrated Freight into one of the nation's premier dry and refrigerated freight companies."

The acquisition of Cross Creek Trucking will increase Integrated Freight's nationwide fleet to over 300 tractors and 650 trailers while expanding the Company's shipping reach into the Pacific Northwest. The transaction was effective as of April 1st and was completed with a combination of cash, equity, and debt.

"Strategically, Cross Creek fits in perfectly with what we're trying to build here at Integrated," said Paul Henley, CEO of Integrated Freight. "We've kept our eyes open for a successful and well respected operator in this region of the country, and they fill that need exceptionally well. The combination of Cross Creek with our current operators will result in more routes, additional customers, and a better bottom line across the fleet."

Integrated Freight Corporation is a Sarasota, Florida headquartered motor freight company providing long-haul, regional and local service to its customers. The Company specializes in dry and refrigerated truckload services, operating primarily in well-established traffic lanes in the Upper Midwest, Pacific Northwest, Texas, California and the Atlantic seaboard. Integrated Freight was formed for the purpose of acquiring and consolidating operating motor freight companies. IFCR completed its fourth acquisition in April of 2011 and in February 2011 reported fiscal third quarter revenues of $10.34M.

The foregoing press release contains forward-looking statements, including statements regarding the company's expectation of its future business and earnings, subject to the safe-harbor provisions for forward-looking statements provided in the Securities Exchange Act and the regulations there under. These forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the company's control. Actual results could differ materially from these forward-looking statements.

[NinaD]

Top 3 "Solar" Penny Stocks
Nuclear power is dominating the headlines as the situation at the Fukushima Daiichi power plant in Japan continues to raise new concerns. In its wake, a number solar companies that could experience dramatic uptrends as traders seek stocks that will benefit from the disaster and the growing disdain with nuclear power .
We found three penny stocks / micro caps that have a solid balance of fundamentals and innovation:

Akeena Solar, Inc. d/b/a Westin (NasdaqCM:WEST)
Westinghouse Solar is a designer and manufacturer of solar power systems. Award winning Westinghouse Solar Power Systems provide the best combination of safety, performance and reliability, while backed by the proven quality of the Westinghouse name. For more information on Westinghouse Solar, visitwww.westinghousesolar.com.



Ascent Solar Technologies, Inc. (NasdaqGM:ASTI)
Ascent Solar Technologies, Inc. is a developer of thin-film photovoltaic modules with substrate materials that can be more flexible and affordable than most traditional solar panels. Ascent Solar modules can be directly integrated into standard building materials, commercial transportation, automotive solutions, space applications, consumer electronics for portable power or configured as stand-alone modules for large scale terrestrial deployment. Ascent Solar is headquartered in Thornton, Colo. Additional information can be found atwww.ascentsolar.com.



Real Goods Solar, Inc. (NasdaqGM: RSOL)
Real Goods Solar, Inc. is a leading residential and commercial solar energy integrator, having installed over 6,500 solar systems. Real Goods Solar offers turnkey solar energy services, and has 33 years of experience in solar energy, beginning with the sale in 1978 of the first solar photovoltaic, or PV, panels in the United States. For more information about Real Goods Solar, please visit www.realgoodssolar.com, or call [phone].



IMPORTANT NOTE: We do not hold a position in any stock mentioned herein nor do we plan to build a position nor have we been compensated in any manner. Never invest in any stock mentioned on this site without consulting an investment advisor. We are not licensed, all information here is opinion. Please see our disclaimer for complete details.

Top 3 "Solar" Penny Stocks

[NinaD]

5 Penny Stocks Under $1 Big Revenues

Some things in life are just not that common. Like penny stocks or micro cap stocks trading below the $1.00 mark that have over $100M in revenues.

MKTG, INC (OTC BB: CMKG.OB ) $0.83 / $105.67 Revenues
MKTG INC is a full service marketing agency headquartered in New York with full service offices in San Francisco, Los Angeles, Chicago and Cincinnati. The Company currently serves a variety of the world’s most recognizable brands. Its services include experiential marketing, digital marketing, retail promotions and strategic research and planning. The firm’s programs help its clients profitably connect with consumers and create networks of brand advocates to generate brand awareness and higher sales for its customers. For more information, please visit www.mktg.com.

BioFuel Energy Corp. (NasdaqGM: BIOF ) $0.82 / $432.54M Revenues
BioFuel Energy Corp. engages in the production and sale of ethanol and its co-products primarily in the United States. The company has two ethanol plants that produce 115 million gallons of ethanol per year, which are located in Wood River, Nebraska and Fairmont, Minnesota. It sells its products to its third party marketer and distributor. The company was founded in 2006 and is headquartered in Denver, Colorado.

AUTOINFO INC (OTC BB: AUTO.OB ) $0.70 / $279.79M Revenues
AutoInfo, Inc., through its subsidiaries, operates as a non-asset based transportation services company in the United States and Canada. It offers transportation capacity and related transportation services to shippers. The company?s services include ground transportation coast to coast, local pick up and delivery, air freight, and ocean freight, as well as warehousing and distribution services. It provides brokerage and contract carrier transportation services through strategic alliances with less than truckload, truckload, air, rail, ocean common carriers, and independent owner-operators. The company?s business services emphasize safety, information coordination, and customer service through a network of independent commissioned sales agents and third party capacity providers. AutoInfo was founded in 1976 and is headquartered in Boca Raton, Florida.

XO HOLDINGS INC (OTC BB: XOHO.OB ) $0.71 / $1.51B Revenues
XO Holdings, Inc., through its subsidiaries, operates as a telecommunications services provider primarily in the United States. It delivers an array of telecommunications solutions to enterprises, businesses, government customers, telecommunications carriers and service providers, and Internet content providers. The company provides its services using Internet protocol (IP) and time division multiplexing technologies. It offers broadband services, including IP Flex, Internet access, carrier voice over Internet protocol origination and termination, Ethernet, and other IP-based solutions, as well as data services, including dedicated private line, Telco collocation, and multi-transport networking. The company?s broadband services also comprise private line point-to-point connectivity that provides special access and point-to-point circuits for use as primary and back-up circuits; and universal site-to-site connectivity services, as well as MPLS-enabled Internet protocol virtual private network services. In addition, it provides fixed wireless services comprising wireless backhaul, network extensions, network redundancy, and diversity services using broadband radio signals transmitted between points of presence located within line-of-sight; managed services, such as network, equipment, and professional services; and interactive voice response services that provide custom-designed voice response systems. Additionally, the company offers voice services, including standard dial tone, retail local and long distance services, basic business lines, switched trunks, messaging, voice and Web conferencing, and carrier reciprocal access; and hosting and hosted applications, such as Web hosting, messaging, collaboration, and software-as-a-service applications to help customers manage their online business, as well as provides a portfolio of integrated and voice services. XO Holdings, Inc. was founded in 1994 and is headquartered in Herndon, Virginia.

Cybex International, Inc. (NasdaqGM: CYBI ) $0.87 / $117M Revenues
Cybex International, Inc. is a leading manufacturer of premium exercise equipment primarily for commercial use. The CYBEX product line, including a full range of strength and cardio training machines, is designed using exercise science to reflect the natural movement of the human body. Led by the Cybex Institute for Exercise Science, CYBEX fitness equipment is engineered to produce optimal results for users from the first-time exerciser to the professional athlete. Products are available for a wide range of facilities, from commercial health clubs to home gyms, and are sold in more than 85 countries worldwide. For more information on CYBEX and its product lines, visit the Company’s website at www.cybexintl.com. Patrick House is a paid endorser for CYBEX products. His weight loss results may be atypical and individual results may vary.

IMPORTANT NOTE: We do not hold a position in any stock mentioned herein nor do we plan to build a position nor have we been compensated in any manner. Never invest in any stock mentioned on this site without consulting an investment advisor. We are not licensed, all information here is opinion. Please see our disclaimer for complete details.

5 Penny Stocks Under $1 Big Revenues

[NinaD]

OMTK UP 169% On EPA News

We like penny stocks with big ideas. Even if they are currently a thinly traded penny stock like Omnitek Engineering Corp. (OTCBB:OMTK). OMTK develops and sells new natural gas engines, as well as proprietary diesel-to-natural gas conversion systems, providing global customers with innovative alternative energy and emissions control solutions that are sustainable, affordable and designed to combat global warming.

Yesterday the EPA ammended its regulations applicable to certifying and converting diesel and gasoline engines to operate on natural gas. This could be a big milestone for the alternative fuel industry and a significant advancement in lessening dependence on foreign oil.

CEO Warner Funk said of the news, “Converting diesel engines to operate on either liquefied natural gas or compressed natural gas provides an economical and environmental solution to new engine replacement. This EPA amendment will now enable our company to certify and convert diesel engines in a cost-effective manner and introduce the technology to the U.S. market,” said Werner Funk, president and chief executive officer of Omnitek Engineering Corporation.



Omnitek Engineering Sees New EPA Regulations as a Milestone for Engine Conversions

Anticipates Strong Domestic Demand for Its Diesel-to-Natural Gas Conversion Technology

SAN MARCOS, Calif., Mar 31, 2011 (GlobeNewswire via COMTEX) — Omnitek Engineering Corporation (OTCQB:OMTK) today said a U.S. Environmental Protection Agency (EPA) amendment this week to regulations applicable to certifying and converting diesel and gasoline engines to operate on natural gas is a milestone for the alternative fuel industry and a significant advancement in lessening dependence on foreign oil.

The ruling, which clarifies and streamlines “conversion manufacturer processes,” will take effect upon publication in the Federal Register, according to the EPA.

“Converting diesel engines to operate on either liquefied natural gas or compressed natural gas provides an economical and environmental solution to new engine replacement. This EPA amendment will now enable our company to certify and convert diesel engines in a cost-effective manner and introduce the technology to the U.S. market,” said Werner Funk, president and chief executive officer of Omnitek Engineering Corporation.

He noted that Omnitek’s technology has been utilized outside the United States since 2001, with more than 5,000 engine conversions currently in operation. “Our technology meets all applicable emission standards, as will be demonstrated in the certification process, and we anticipate tremendous demand for Omnitek’s conversion kits– particularly from heavy-duty, light truck and bus operators,” Funk said.

“We also endorse the proposed Natural Gas Act and the general premise outlined in The Pickens Plan that seeks to dramatically reduce dependency on foreign oil through the utilization of natural gas,” Funk said.

Funk added that compressed natural gas provides significant advantages over diesel fuel, including reduced emissions, plentiful supplies and favorable economics. “Industry observers believe that up to eight million heavy-duty vehicles in the U.S. could benefit from conversion to natural gas. Replacing old diesel trucks with new natural gas-powered trucks is certainly an option, but it is much more expensive and manufacturing the required quantity of new engines has a very large ‘carbon-footprint’ consequence. Our technology is feasible and affordable, with a projected return on investment of less than two years. In addition, diesel engines have a service life of up to 20 years, which provides an additional incentive to convert,” Funk said.

About Omnitek Engineering Corporation

Omnitek Engineering Corp. develops and sells new natural gas engines, as well as proprietary diesel-to-natural gas conversion systems — providing global customers with innovative alternative energy and emissions control solutions that are sustainable, affordable and designed to combat global warming.

Some of the statements contained in this news release discuss future expectations, contain projections of results of operations or financial condition or state other “forward-looking” information. These statements are subject to known and unknown risks, uncertainties, and other factors that could cause the actual results to differ materially from those contemplated by the statements. The forward-looking information is based on various factors and is derived using numerous assumptions. Important factors that may cause actual results to differ from projections include, among many others, the ability of the Company to raise sufficient capital to meet operating requirements, completion of R&D and successful commercialization of products/services, patent completion, prosecution and defense against well-capitalized competitors. These are serious risks and there is no assurance that our forward-looking statements will occur or prove to be accurate. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” and variations of such words and similar expressions are intended to identify such forward-looking statements. Unless required by law, the Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

IMPORTANT NOTE: We do not hold a position in any stock mentioned herein nor do we plan to build a position nor have we been compensated in any manner. Never invest in any stock mentioned on this site without consulting an investment advisor. We are not licensed, all information here is opinion. Please see our disclaimer for complete details.

OMTK UP 169% On Epa News

[NinaD]

Top 3 Rated Big Board Micro Caps

Morning Traders. We typically find our penny stock and micro cap opportunities on the OTCBB and Pink Sheets. However, as we mentioned last week in our blog, sometimes the established companies on the AMEX NYSE and NASDAQ can provide some of the highest rated opportunities in the micro cap market.

Below are todays Top 3 Micro Caps (under $2.00) with Strong Buy recommendations from analysts.

#1 Brigus Gold Corp. (AMEX:BRD)

Brigus is a growing gold producer committed to maximizing shareholder value through a strategy of efficient production, targeted exploration and select acquisitions. The Company operates the wholly owned Black Fox Complex in the Timmins gold district of Ontario, Canada. The Black Fox Complex encompasses the Black Fox Mine and Mill, and adjoining Grey Fox-Pike River property, all in the Township of Matheson, Ontario, Canada. Brigus is also advancing its Goldfields Project located near Uranium City, Saskatchewan, Canada, which hosts the Box and Athona gold deposits. In Mexico, Brigus holds a 100% interest in the Ixhuatan Project located in the state of Chiapas. In the Dominican Republic, Brigus Gold has a joint venture covering three mineral exploration projects.

#2 Kimber Resources, Inc. (AMEX:KBX)

Kimber owns mineral concessions covering in excess of 39,000 hectares in the prospective Sierra Madre gold-silver belt, including the Monterde property, where three gold-silver mineral resources have already been defined. The most advanced of these, the Carmen deposit, has been extensively drilled and has undergone detailed geologic modeling. The completion of the preliminary assessment for Monterde in 2010 represented a significant step forward for Kimber and is expected to lead to further development and more advanced economic studies at the Monterde deposits including the completion of a pre-feasibility study during 2011.

#3 Longwei Petroleum Investment Hold Ltd (NYSE:LPH)

Longwei Petroleum Investment Holding Limited is an energy company engaged in the storage and distribution of finished petroleum products in the People’s Republic of China. The Company’s oil and gas operations consist of transporting, storage and selling finished petroleum products, entirely in the PRC. The Company’s headquarters are located in Taiyuan City, Shanxi Province. The Company has a storage capacity for its products of 120,000 metric tons located at storage facilities in Taiyuan and Gujiao, Shanxi. The Company’s Taiyuan and Gujiao facilities can store 50,000 metric tons and 70,000 metric tons, respectively. The Company has the necessary licenses to operate and sell petroleum products not only in Shanxi but throughout the entire PRC. The Company’s storage tanks have the largest storage capacity of any non-government operated entity in Shanxi.

IMPORTANT NOTE: We do not hold a position in any stock mentioned herein nor do we plan to build a position nor have we been compensated in any manner. Never invest in any stock mentioned on this site without consulting an investment advisor. We are not licensed, all information here is opinion. Please see our disclaimer for complete details.

Top 3 Rated Big Board Micro Caps

[NinaD]

Best Online Broker For Penny Stocks

We get a lot of emails from subscribers wondering which online broker is best for trading penny stocks. Well, here’s a simple chart prepared by our friends at Chroma Investing with all the answers!

Best Online Broker For Penny Stocks

[NinaD]

CTSO Up 88% On Strong News

There is no shortage of penny stocks with products that are “awaiting” approval from whatever regulatory body oversees their industry. In the case of a penny stock trading below $0.50 that has a blood purification product to treat certain life-threatening illnesses, approval of the product can have a strong impact on traders across the board.

That is the case with CytoSorbents Corporation (OTCBB:CTSO) and their CytoSorb(TM) product which has met the safety and label efficacy claim requirements of the European Medical Devices Directive and can now be sold in the European Union (E.U.) for human clinical use.

This means manufacturing can commence which means revenues should follow. The market agrees today as shares are currently up 88% on record volume.



CytoSorbents Corporation Achieves European Union Regulatory Approval for CytoSorb(TM)
MONMOUTH JUNCTION, NJ, Mar 31, 2011 (MARKETWIRE via COMTEX) — CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company using blood purification to treat life-threatening illnesses, is pleased to announce that it has achieved European CE Mark approval for its flagship product, CytoSorb(TM), as an extracorporeal cytokine filter in situations where excessive cytokine levels exist. This milestone certifies that CytoSorb(TM) has met the safety and label efficacy claim requirements of the European Medical Devices Directive and can now be sold in the European Union (E.U.) for human clinical use.

The European Sepsis Trial has successfully demonstrated CytoSorb(TM)’s robust ability to reduce circulating plasma cytokine levels during the extracorporeal treatment of critically-ill patients with sepsis and respiratory failure. CytoSorb(TM) has achieved its primary endpoint of IL-6 (interleukin-6) reduction with statistical significance based on an interim analysis of the trial. The data demonstrates that CytoSorb(TM) plus standard of care therapy reduced IL-6 levels by an average of 49.1% (p = 0.01) during the CytoSorb(TM) treatment period compared to standard of care therapy alone. The treatment was well-tolerated, with no serious device related adverse events reported to date in more than 300 treatments in septic patients.

Dr. Phillip Chan, Chief Executive Officer, stated, “Obtaining European regulatory approval for CytoSorb(TM) is the most significant accomplishment in our company’s history and we thank our employees and our shareholders for their dedication and support. To our knowledge, we are the only device approved in the E.U. specifically as a cytokine filter, opening up many opportunities to not just treat patients with sepsis, but also patients with a host of life-threatening and non-life threatening inflammatory conditions where cytokine levels are elevated. As we analyze the clinical data from our current trial in sepsis, we look to continue to lead and foster additional clinical studies with a strong focus on sepsis and other critical care illnesses such as acute respiratory distress syndrome, severe burn injury, trauma, and pancreatitis, where the need is great and the human and financial costs are staggering. The goal is to drive broad usage of our technology and generate valuable clinical data across many fields.”

Dr. Chan continued, “Now that we are permitted to manufacture CytoSorb(TM) devices for clinical use in the E.U. under CE Mark approval and ISO 13485 certification, we will ramp manufacturing for a controlled-market release in select territories in the second half of this year. The goal for 2011 is to build a solid foundation for future growth and responsibly make the transition from a development stage to a commercial stage medical device company. Our longer term goal is to pursue trials in the U.S. and attain FDA regulatory approval as well.” Dr. Chan concluded, “With this major milestone, we continue to advance our mission to change the face of critical care medicine and to help save patients’ lives.”

About CytoSorbents and CytoSorb(TM)

CytoSorbents Corporation is a critical care focused therapeutic device company in clinical trials to treat severe sepsis, the end result of “overwhelming infection,” with a novel blood purification device called CytoSorb(TM). Severe sepsis afflicts more than 1 million people in the United States (U.S.), 1.5 million people in the European Union (E.U.), and an estimated 18 million people worldwide each year, killing one in every three patients despite the best medical treatment. In the U.S., more die from severe sepsis than from either heart attacks, strokes or any single form of cancer. Severe sepsis is typically triggered by bacterial infections like pneumonia, or viral infections like influenza. However, it is the body’s abnormal immune response to the trigger that leads to severe inflammation and the unregulated, massive production of cytokines, often called “cytokine storm,” that then causes multi-organ failure and often death. CytoSorb(TM) is a cartridge containing highly porous polymer beads that are designed to filter cytokines and treat potentially fatal cytokine storm. As blood is pumped repeatedly through the CytoSorb(TM) cartridge using standard dialysis equipment, the beads bind and remove cytokines and other toxins from blood. The treated blood is then returned to the patient. The Company is finalizing its European Sepsis Trial — a multi-center, randomized, controlled clinical trial using CytoSorb(TM) to treat up to 100 patients with severe sepsis in the setting of respiratory failure. Importantly, cytokine reduction via CytoSorb(TM) has broad applicability to a number of other critical care diseases where cytokine storm plays a detrimental role, including burn and smoke inhalation injury, trauma, acute respiratory distress syndrome, advanced influenza, acute pancreatitis and others. In March 2011, the Company successfully achieved CE Mark approval to market its CytoSorb(TM) device as an extracorporeal cytokine filter. CytoSorbents has also achieved ISO 13485:2003 Full Quality Systems certification, an internationally recognized quality standard designed to ensure that medical device manufacturers have the necessary comprehensive management systems in place to safely design, develop, manufacture and distribute medical devices in the E.U. Assuming availability of adequate and timely funding, and continued positive results from our clinical studies, the Company intends to begin commercializing its product in Europe and then seek to commence clinical trials in the U.S. for approval. CytoSorb(TM) is one of a number of different resins the Company has designed for various medical applications, including improved dialysis, the potential treatment of inflammatory and autoimmune disorders, rhabdomyolysis in trauma, removal of chemotherapy drugs during treatment of cancer with high dose regional chemotherapy, drug detoxification, and others. Additional information is available for download on the Company’s website: www.cytosorbents.com

Forward-Looking Statements

This press release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release are not promises or guarantees and are subject to risks and uncertainties that could cause our actual results to differ materially from those anticipated. These statements are based on management’s current expectations and assumptions and are naturally subject to uncertainty and changes in circumstances. We caution you not to place undue reliance upon any such forward-looking statements. Actual results may differ materially from those expressed or implied by the statements herein. CytoSorbents Corporation and CytoSorbents, Inc believe that its primary risk factors include, but are not limited to: obtaining government approvals including required FDA and additional CE Mark approvals; ability to successfully develop commercial operations; dependence on key personnel; acceptance of the Company’s medical devices in the marketplace; the outcome of pending and potential litigation; compliance with governmental regulations; reliance on research and testing facilities of various universities and institutions; the ability to obtain adequate and timely financing in the future when needed; product liability risks; limited manufacturing experience; limited marketing, sales and distribution experience; market acceptance of the Company’s products; competition; unexpected changes in technologies and technological advances; and other factors detailed in the Company’s Form 10-K filed with the SEC on March 31, 2011, which is available at http://www.sec.gov.

IMPORTANT NOTE: We do not hold a position in any stock mentioned herein nor do we plan to build a position nor have we been compensated in any manner. Never invest in any stock mentioned on this site without consulting an investment advisor. We are not licensed, all information here is opinion. Please see our disclaimer for complete details.

[NinaD]

Penny Stock Trading: 4 Basic Rules

Developing a mindset for penny stock trading comes with time. Micro cap stocks are risky investments for any investor whether you’ve got 1 or 20 years trading experience. You could lose every nickel of a penny stock trade if you don’t embrace what we believe are the “4 Basic Rules of Penny Stock Trading”.

(1) Use Limit Orders: Don’t put in a “market order” to buy a penny stock. Market makers will fill your order where they want to and it could be much higher than you want. Use limit orders when you buy, pay what YOU want NOT what the market makers want. The penny stock market can be the “Wild West” when it comes to executing orders so give yourself the best chance to book profits, use limit orders.

(2) Watch The Open: The future of a stock for the day is often told in the first 30 mins or less. When a penny stock experiences high volume BUT remains flat with little or no increase, this is not a good sign. Big selling early means selling will typically continue and the stock will likely weaken throughout the day. On the other hand, good movement early could mean sellers are laying off. If it’s moving and your limit order is filled where you want then you’re half way home to making gains.

(3) Don’t Chase: If your order does NOT get filled where you wanted and the price is running, don’t chase it. Know there will always be a new penny stock opportunity and chasing them up limits your odds of winning in the end. The window of opportunity on penny stocks can be very small. If the you miss the window you will only be buying someone else’s profits on the way down. Trust your read on what happens at the open, put your limit order in and then let the market Gods dictate if you are going to be in this one or not. If you are, see Rule 4.

(4) Book Profits When You Can: Greed with penny stocks typically costs you far more than it makes you. Thinking “this could be the big one” sounds fun but it’s not practical and it’s not going to help you consistently book profits with penny stocks. If you can book gains from 10%-50% and move on, do it. More profits have been lost as traders fall victim to their own greed.
WallStreetGazette.net

[PLUTUS]

MMTE & CATA next week! Bank on it

[NinaD]

GDGI might be time to book profits on this, imo

[NinaD]

GDGI 10d avg vol 159k...todays vol 7.7M and counting!

[NinaD]

HMLA up over 30% on record volume. Watch it.